GGrantIndex
Sort

64,565 grants matching drug discovery

Mycobacterial DNA repair and mutagenesis

$663,906
Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2020 · AI

Optimizing HIV Treatment Monitoring under Resource Constraints

$663,842
Joseph W Hogan · Brown University · R01 · FY2019 · AI

M1 PAMs for Age-Related Cognitive Impairments

$663,797
Carrie Kimberly Jones · Vanderbilt University · R01 · FY2017 · AG

Administrative Core

$663,762
Robert E. Lewis · University Of Nebraska Medical Center · P20 · FY2019 · GM

A Rapid Assay for RNA Targeted Drugs

$663,747
Dev Priya Arya · Nubad, Llc · R42 · FY2015 · GM

Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimer’s Disease

$663,720
Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AG

Development of Protein Degraders Targeting EZH2 Non-enzymatic Functions in Prostate Cancer

$663,713
Jindan Yu · Emory University · R01 · FY2024 · CA

Organs-on-Chips as a Platform for Studying Effects of Microgravity on Human Physiology: Blood-Brain Barrier-Chip in Health and Disease

$663,593
Christopher D. Hinojosa · Emulate, Inc. · UG3 · FY2018 · TR

Development of Novel Antiviral Agents VS West Nile Virus

$663,507
Washington University · U01 · FY2003 · AI

Assembly and export of mycobacterial lipoglycans

$663,504
Mary Jackson · Colorado State University · R01 · FY2022 · AI

Bronchiolitis Obliterans: Discovery and Therapy

$663,454
Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2023 · HL

Chemical disarming of drug resistance in Mycobacterium tuberculosis

$663,411
Christina Leigh Stallings · Washington University · R01 · FY2021 · AI

Paul Calabresi Clinical Oncology Award

$663,405
Scott Kopetz · University Of Tx Md Anderson Can Ctr · K12 · FY2023 · CA

Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa

$663,361
Myron E Essex · Harvard School Of Public Health · R01 · FY2010 · AI

Small molecule Hsp90 inhibitors in AD treatment

$663,271
Gabriela Chiosis · Sloan-Kettering Inst Can Research · U01 · FY2014 · AG

Synthetic mRNA-mediated reversible immunocontraception

$663,083
Philip J Santangelo · Emory University · R33 · FY2023 · HD

Deterrents for prescription opioid abuse

$663,080
Kevin B. Freeman · University Of Mississippi Med Ctr · R01 · FY2021 · DA

A systems biology approach to unravel theunderlying functional modules of ASD

$663,063
Lilia M Iakoucheva · University Of California, San Diego · R01 · FY2009 · HD

DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS

$663,058
Texas Agrilife Research · P01 · FY2000 · AI

Maternal mediators of fetal growth restriction linked to prenatal alcohol exposure

$662,988
Christina Chambers · University Of California, San Diego · R01 · FY2022 · AA

Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning

$662,943
Steven E Patterson · University Of Minnesota · U01 · FY2022 · NS

AP 1. Biodiversity

$662,886
Gary Rosenberg · University Of Utah · U19 · FY2018 · TW

Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis

$662,861
Andrew Emili · Boston University Medical Campus · R01 · FY2021 · AI

Molecular Analysis of Hotspots of Genetic Recombination

$662,802
Gerald R Smith · Fred Hutchinson Cancer Research Center · R01 · FY2012 · GM

Structure-based inhibition of chemokine signaling in the inflamed pancreas

$662,744
Brian F Volkman · Medical College Of Wisconsin · R01 · FY2023 · DK